Speakers
Dr. Melissa Van Pel
NecstGen
Head of Cell Therapy
At the event, Dr. van Pel will share her insights on the Netherlands' potential as a hub for CAR-T and cell therapy organizations. Her expertise will provide valuable perspectives on the opportunities and challenges in this rapidly evolving field.
About Dr. Melissa van Pel
Dr. Melissa van Pel leads NecstGen's efforts in advancing cell and gene therapies, focusing on bioprocess development and biopharmaceutical manufacturing. Her extensive experience includes coordinating cell therapy projects and ensuring the quality of advanced therapy medicinal products.
NecstGen
Together, we challenge today’s possibilities and enable the unthinkable.
The Netherlands Center for the Clinical Advancement of Stem Cell and Gene Therapies (NecstGen) comprises a state-of-the-art facility for development and GMP manufacturing. NecstGen additionally offers cleanroom rental to allow organisations to maintain control of production while de-risking the capital investment required.
NecstGen is open to the world and supports academic, small, and large industrial therapy developers to translate research and early-stage clinical programs into patient treatments. One of NecstGen’s primary aims is to support the development of therapeutics for orphan diseases that may be underserved but are nevertheless catastrophic to people who suffer from them.
Partners of Single-Use Event 2025
Single-Use Event 2025
Registration website for Single-Use Event 2025Single-Use Event 2025marketing@aleapublishers.nl
Single-Use Event 2025marketing@aleapublishers.nlhttps://www.single-use.nu/159119
2025-09-16
2025-09-16
OfflineEventAttendanceMode
EventScheduled
Single-Use Event 2025Single-Use Event 20250.00EUROnlineOnly2019-01-01T00:00:00Z
To be announcedTo be announced
event registration made easy
aanmelder.nl is the software partner for events.
Click here to discover the software.